Combination vaccines and immunization visits

Pediatric Infectious Disease Journal

Volumn 15, Issue 2, 1996, Pages 103-105

  Plotkin, Stanley A ^a,b   Fletcher, Mark A ^a  

^a Pasteur Merieux Connaught   (France)

^b Pasteur Mérieux Connaught ^*  (France)

Author keywords

Combination vaccines; immunization visits

Indexed keywords

VACCINE;

BACTERIAL INFECTION; COMBINATION CHEMOTHERAPY; DIPHTHERIA; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION; INFECTION CONTROL; MEASLES; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; TETANUS; TUBERCULOSIS;

EID: 0030021211     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199602000-00002     Document Type: Review

References (33)

1. Plotkin SA. Vaccination in the 21st century. J Infect Dis 1993;168:29-37.
2. Donnely JJ, Ulmer JB, Liu MA. Immunization with DNA. J Immunol Methods 1994;176:145-52.
3. Second European Conference on Vaccinology: combined vaccines for Europe, pharmaceutical, regulatory and policymaking aspects. New York: Academic Press, 1994.
4. Williams JC, Goldenthal KL, Burns DL, Lewis BP, eds. Combined vaccines and simultaneous administration: current issues and perspectives. In: Annals of the New York Academy of Sciences, vol 754. New York: New York Academy of Sciences, 1995.
5. Robbins A. The children's vaccine initiative. Am J Dis Child 1993;147:152-3.
6. Ward J, Lieberman JM, Cochi SL. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA Jr., eds. Vaccines. Philadelphia: Saunders, 1994:337-86.
7. Gold R, Lepow ML. Immune response of human infants to polysaccharide vaccines of Groups A and C Neisseria meningitidis. J Infect Dis 1977;136(Suppl.):S31-5.
8. Reingold AL, Broome CV, Hightower AW, et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 1985;2:114-8.
9. Temple K, Greenwood B, Inskip H, Hall A, Koskela M, Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in African children. Pediatr Infect Dis J 1991;10:386-90.
10. Halsey N, Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull WHO 1985;63:1151-69.
11. Ward J, Lieberman JM, Cochi SL. Measles vaccine. In: Plotkin SA, Mortimer EA Jr., eds. Vaccines. Philadelphia: Saunders, 1994:229-76.
12. Sabin AB, Michaels RH, Krugman S, Eiger ME, Berman PH, Warren J. Effect or oral poliovirus vaccine in newborn children: 1. Excretion of virus after ingestion of large doses of type 1 or of mixture of all three types, in relation to level of placentally transmitted antibody. Pediatrics 1963;31:623-40.
13. Cooney ML, Fox JP, Hall CE. The Seattle virus watch: VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am J Epidemiol 1975;101:532-51.
14. Hall CB, Geiman JM, Biggar R, Kotok DI, Douglas GR Jr. Respiratory syncytial virus infections within families. N Engl J Med 1976;294:414-9.
15. Wenman WM, Hinde D, Feltham S, Gurwith M. Rotavirus infection in adults: results of a prospective family study. N Engl J Med 1979;301:303-6.
16. Cherry JD, Feigen RD, Lobes JA Jr., et al. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr 1972;81:217-30.
17. Smith FR, Curran AS, Raciti A, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr 1982;101:391-3.
18. O'Shea S, Best JM, Banatvala JE. Viremia, virus excretion and antibody responses after challenge to volunteers with low levels of antibody to rubella virus. J Infect Dis 1983;148:639-47.
19. Forsgren M, Soren L. Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus of the fetus. Scand J Infect Dis 1985;17:337-41.
20. Nishio O, Ishihara Y, Sakae K, et al. The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years. J Biol Stan 1984;12:1-10.
21. Whittle HC, Maine N, Pilkington J, et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995;345:1089-92.
22. Xu ZY, Duan SC, Margolis HS, et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. J Infect Dis 1995;171:54-60.
23. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-6.
24. Bottiger M, Pettersson G. Vaccine immunity to diphtheria: 20-year follow-up study. Scand J Infect Dis 1992;24:753-8.
25. Anonymous. Diphtheria epidemic: new independent states of the former Soviet Union, 1990-1994. MMWR 1995;44:177-81.
26. Gross PA, Quinnan GV Jr., Weksler ME, Setia U, Douglas RG Jr. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989;7:303-8.
27. Berger R, Florent G, Just M. Decrease of the lymphoproliferative response to varicella zoster virus antigen in the aged. Infect Immun 1981;32:24-7.
28. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 1992;166:253-9.
29. Clemens JD, Ferrecio C, Levine MM, et al. Impact of Hae- mophilus influenzae type b polysaceharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992;267:673-8.
30. Scheifele D, Bjornson G, Guasparini R, Meekison W. Is Haemophilus influenzae type B conjugated vaccine (meningococcal protein conjugate) compatible with diphtheriapertussis-tetanus vaccine in young infants? Pediatr Infect Dis J 1993;12:952-4.
31. Halperin SA, Eastwood BJ, Langley JM. Immune responses to pertussis vaccines concurrently administered with viral vaccines. Ann NY Acad Sci 1995;754:89-96.
32. Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann NY Acad Sci 1995;754:35-47.
33. Johansson BE, Moran RM, Kilbourne ED. Antigenpresenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc Natl Acad Sci USA 1987;84:6869-73.